Construction and characterization of attenuated delta aroA delta virG Shigella flexneri 2a strain CVD 1203, a prototype live oral vaccine - PubMed (original) (raw)

Construction and characterization of attenuated delta aroA delta virG Shigella flexneri 2a strain CVD 1203, a prototype live oral vaccine

F R Noriega et al. Infect Immun. 1994 Nov.

Abstract

We engineered an oral Shigella vaccine prototype that can invade intestinal epithelial cells but cannot undergo extensive intracellular replication or extend to adjacent epithelial cells. Strain CVD 1203, derived from wild-type Shigella flexneri 2a by introducing deletions in chromosomal aroA and invasion plasmid virG, was highly attenuated in the Sereny test. Two 10(9)-CFU orogastric doses (2 weeks apart) stimulated production of secretory immunoglobulin A antibodies to S. flexneri 2a and protected against conjunctival sac challenge with virulent S. flexneri 2a.

PubMed Disclaimer

References

    1. Proc Natl Acad Sci U S A. 1989 May;86(10):3867-71 -PubMed
    1. Vaccine. 1991 Jan;9(1):6-9 -PubMed
    1. Am J Epidemiol. 1972 Jul;96(1):40-9 -PubMed
    1. Infect Immun. 1983 Aug;41(2):742-50 -PubMed
    1. Infect Immun. 1992 Jun;60(6):2218-24 -PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources